Medline is preparing to test investor appetite for one of the largest healthcare offerings in years, seeking a public valuation that could reach roughly $55 billion and cement its status as a dominant ...

Medline is planning an IPO, which might occur between late 2025 and early 2026, aiming for a $5 billion raise. Investors can't buy Medline stock now; consider similar public firms like Cardinal Health ...